PL441645A1 - Sposób odróżniania złośliwych i łagodnych guzków tarczycy - Google Patents

Sposób odróżniania złośliwych i łagodnych guzków tarczycy

Info

Publication number
PL441645A1
PL441645A1 PL441645A PL44164522A PL441645A1 PL 441645 A1 PL441645 A1 PL 441645A1 PL 441645 A PL441645 A PL 441645A PL 44164522 A PL44164522 A PL 44164522A PL 441645 A1 PL441645 A1 PL 441645A1
Authority
PL
Poland
Prior art keywords
thyroid nodule
malignant thyroid
differentiating benign
genes
thyroid
Prior art date
Application number
PL441645A
Other languages
English (en)
Inventor
Jolanta Krajewska
Alicja Płuciennik
Małgorzata OCZKO-WOJCIECHOWSKA
Aleksander Płaczek
Michał JARZĄB
Sebastian Student
Agata Wilk
Agnieszka Czarniecka
Aleksandra Pfeifer
Agnieszka Kotecka-Blicharz
Krzysztof Łakomiec
Ewa Chmielik
Dorota Słowińska-Klencka
Marek Dedejcus
Barbara JARZĄB
Krzysztof Fujarewicz
Original Assignee
Narodowy Instytut Onkologii Im. Marii Skłodowskiej-Curie-Państwowy Instytut Badawczy Oddział W Gliwicach
Politechnika Śląska
Polskie Towarzystwo Endokrynologiczne
Uniwersytet Medyczny w Łodzi
Wasko Spółka Akcyjna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Narodowy Instytut Onkologii Im. Marii Skłodowskiej-Curie-Państwowy Instytut Badawczy Oddział W Gliwicach, Politechnika Śląska, Polskie Towarzystwo Endokrynologiczne, Uniwersytet Medyczny w Łodzi, Wasko Spółka Akcyjna filed Critical Narodowy Instytut Onkologii Im. Marii Skłodowskiej-Curie-Państwowy Instytut Badawczy Oddział W Gliwicach
Priority to PL441645A priority Critical patent/PL441645A1/pl
Publication of PL441645A1 publication Critical patent/PL441645A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Przedmiotem zgłoszenia jest sposób różnicowania łagodnych i złośliwych guzków tarczycy w próbce z biopsji, sklasyfikowanej zgodnie z systemem Bethesda, który obejmuje etapy izolacji RNA oraz określenie poziomu ekspresji znormalizowanego zestawu genów, zawierającego geny takie jak AMOT, DCSTAMP, NOD1, SLC26A7, EMP2, EGR1, MPZL2, ITGA2, MET, SLPI, TPO. Do różnicowania guzków tarczycy wykorzystuje się algorytm klasyfikatora, który nauczony jest na danych ekspresji genów skorelowanych z charakterem guzka tarczycy. Ponadto ustala się prawdopodobieństwo złośliwości badanej próbki.
PL441645A 2022-07-05 2022-07-05 Sposób odróżniania złośliwych i łagodnych guzków tarczycy PL441645A1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL441645A PL441645A1 (pl) 2022-07-05 2022-07-05 Sposób odróżniania złośliwych i łagodnych guzków tarczycy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL441645A PL441645A1 (pl) 2022-07-05 2022-07-05 Sposób odróżniania złośliwych i łagodnych guzków tarczycy

Publications (1)

Publication Number Publication Date
PL441645A1 true PL441645A1 (pl) 2024-01-08

Family

ID=89473649

Family Applications (1)

Application Number Title Priority Date Filing Date
PL441645A PL441645A1 (pl) 2022-07-05 2022-07-05 Sposób odróżniania złośliwych i łagodnych guzków tarczycy

Country Status (1)

Country Link
PL (1) PL441645A1 (pl)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2569626A2 (en) * 2010-05-11 2013-03-20 Veracyte, Inc. Methods and compositions for diagnosing conditions
WO2013138726A1 (en) * 2012-03-15 2013-09-19 Sabiosciences Corp. Thyroid cancer biomarker
US20170329894A1 (en) * 2008-11-17 2017-11-16 Veracyte, Inc. Algorithms for disease diagnostics
EP3467123A2 (en) * 2008-11-17 2019-04-10 Veracyte, Inc. Methods and compositions of molecular profiling for disease diagnostics

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170329894A1 (en) * 2008-11-17 2017-11-16 Veracyte, Inc. Algorithms for disease diagnostics
EP3467123A2 (en) * 2008-11-17 2019-04-10 Veracyte, Inc. Methods and compositions of molecular profiling for disease diagnostics
EP2569626A2 (en) * 2010-05-11 2013-03-20 Veracyte, Inc. Methods and compositions for diagnosing conditions
WO2013138726A1 (en) * 2012-03-15 2013-09-19 Sabiosciences Corp. Thyroid cancer biomarker

Similar Documents

Publication Publication Date Title
Lyra et al. Meeting the challenge of DNA barcoding Neotropical amphibians: polymerase chain reaction optimization and new COI primers
Lincoln et al. Planktonic Euryarchaeota are a significant source of archaeal tetraether lipids in the ocean
Taib et al. Phylogenetic affiliation of SSU rRNA genes generated by massively parallel sequencing: new insights into the freshwater protist diversity
Pawlowski et al. Eukaryotic richness in the abyss: insights from pyrotag sequencing
US8965974B2 (en) Systems and methods for determining user attribute values by mining user network data and information
CN104573410A (zh) 基于分子子网与随机森林分类器的癌症化疗敏感性预测方法
CN105808709A (zh) 人脸识别快速检索方法及装置
CN106384050B (zh) 一种基于最大频繁子图挖掘的动态污点分析方法
CN114003648B (zh) 风险交易团伙的识别方法、装置、电子设备与存储介质
CN112779334B (zh) 一种用于前列腺癌早期筛查的甲基化标志物组合及筛选方法
WO2024066461A1 (zh) 基于宏基因组和宏转录组识别油藏驱油功能微生物的方法
CN115563196B (zh) 一种基于多源数据增强对象信息价值的方法及系统
CN109344263A (zh) 一种地址匹配方法
CN113584175A (zh) 一组评估肾乳头状细胞癌进展风险的分子标记及其筛选方法和应用
PL441645A1 (pl) Sposób odróżniania złośliwych i łagodnych guzków tarczycy
WO2025222814A1 (zh) 预测样本与肿瘤关联关系的方法、设备、介质和程序
EP3102695A1 (en) Process, apparatus or system and kit for classification of tumor samples of unknown and/or uncertain origin and use of genes of the group of biomarkers
Zhu et al. On selection biases with prediction rules formed from gene expression data
PL441643A1 (pl) Sposób różnicowania łagodnych i złośliwych guzków tarczycy
Githaka “Misuse” of RNA‐seq data in microbiome studies: A cautionary tale of poly (A)
CN116930495A (zh) 一种基于单细胞测序的肝癌标志物及其应用
Deng et al. GeneLLM: a large cfRNA language model for cancer screening from raw reads
Wilk et al. On Stability of Feature Selection Based on MALDI Mass Spectrometry Imaging Data and Simulated Biopsy
Kim et al. Prediction of Lung Metastasis from Hepatocellular Carcinoma using the SEER Database
CN112487816B (zh) 一种基于网络分类的命名实体识别方法